Financial News
CRISPR Therapeutics AG - Common Shares (NQ:CRSP)
Headline News about CRISPR Therapeutics AG - Common Shares


$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,300 Today
February 09, 2024
Via Benzinga






Via Benzinga

















Cathie Wood's Ark Invest Sells $8.04M Worth of DraftKings Shares
January 17, 2024
Via Benzinga

Gene Therapy For Beta-Thalassemia: CRISPR Therapeutics/Vertex's Casgevy Secures FDA Nod Ahead of Schedule
January 17, 2024
Via Benzinga
Exposures
Product Safety



Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.